November 26, 2023 RETENTION BONUS AGREEMENTRetention Bonus Agreement • November 28th, 2023 • Harpoon Therapeutics, Inc. • Biological products, (no disgnostic substances)
In recognition of your past and future contributions to the success of Harpoon Therapeutics, Inc. (the “Company”), the Company is happy to inform you that you have been awarded a retention bonus in the amount of $[_________] (the “Retention Bonus”), subject to the terms and conditions set forth in this Retention Bonus Agreement (this “Agreement”). The Retention Bonus, if earned in accordance with the terms of this Agreement, shall be paid to you in two lump sum payment, with 50% of the Retention Bonus paid as soon as administratively practicable following May 26, 2024 and 50% of the Retention Bonus paid as soon as administratively practicable following November 26, 2024 (each, a “Payment Date”). In order for you to receive the Retention Bonus, you must remain employed by the Company on a full time basis and in good standing through the applicable Payment Date. Except as otherwise provided below, if you are not employed by the Company on a Payment Date, then you will forfeit the portion
HARPOON THERAPEUTICS, INC. RESTRICTED STOCK UNIT AWARDRestricted Stock Unit Award Agreement • November 28th, 2023 • Harpoon Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
Harpoon Therapeutics, Inc. (the “Company”) hereby grants the following award in the form of Restricted Stock Units (“Restricted Stock Units” or “RSUs”) pursuant to its 2019 Equity Incentive Plan (the “Plan”). The terms of the grant are set forth in the attached Restricted Stock Unit Award Agreement (the “Agreement”).
